Cladribine to be available to more people with MS
More people with MS will have the option to take cladribine following a recommendation from the National Institute for Health and Care Excellence (NICE). The new recommendation says anyone with relapsing remitting MS who is having relapses or new disease activity visible on MRI scans (known as active MS) may be eligible for cladribine. Previously, it was only […]
Cladribine to be available to more people with MS Read More »